Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice-Reference-Cited by-同舟云学术

Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice

Published:2019-05 Issue:24 Volume:37 Page:3221-3228
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Elikaee Samira,Mohebali Mehdi,Rezaei Sassan,Eslami Hamid,Khamesipour Ali,Keshavarz Hossein,Eshraghian Mohammad Reza

Funder

Tehran University of Medical Sciences

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference42 articles.

1. World Health Organization. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region; 2014.

2. Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013;Holakouie-Naieni;Acta Trop,2017

3. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features;Mohebali;Iran J Parasitol,2013

4. Chemotherapy in the treatment and control of leishmaniasis;Alvar;Adv Parasitol,2006

5. Cutaneous leishmaniasis vaccination: a matter of quality;De Luca;Front Immunol,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

2. Live attenuated Leishmania infantum centrin deleted mutant (LiCen) as a novel vaccine candidate: A field study on safety, immunogenicity, and efficacy against canine leishmaniasis;Comparative Immunology, Microbiology and Infectious Diseases;2023-06

3. Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated Leishmania;Microorganisms;2023-04-16

4. The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection;Vaccines;2023-02-09

5. The Utility of a Controlled Human Infection Model for Developing Leishmaniasis Vaccines;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023